MedTrace Logo

Enteral Nutrition in Congestive Heart Failure and Cardiac Cachexia

NCT00654719 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2008-04-09

No results posted yet for this study

Summary

The purpose of this study was to determine the effects of a high caloric drink on weight and several other clinical markers including quality of life in patients with unintentional weight loss (cachexia) due to chronic heart failure.

Conditions

Interventions

DIETARY_SUPPLEMENT

NutriDrink

Nutritional supplementation that contains 600 kcal/day: protein content 20 g, carbohydrates 72 g, fat 26 g

DIETARY_SUPPLEMENT

Placebo

Nutritional supplementation containing only 12 kcal/day

Sponsors & Collaborators

  • Nutricia Research Fundation

    collaborator OTHER

  • National Heart and Lung Institute

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-04-30
Primary Completion
2002-02-28
Completion
2002-02-28

Countries

  • Germany
  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00654719 on ClinicalTrials.gov